Tonix Pharmaceuticals Holding (TNXP) Profit After Tax: 2023-2025
Historic Profit After Tax for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -$31.8 million.
- Tonix Pharmaceuticals Holding's Profit After Tax fell 101.02% to -$31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.0 million, marking a year-over-year increase of 30.87%. This contributed to the annual value of -$136.7 million for FY2024, which is 17.18% down from last year.
- According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Profit After Tax is -$31.8 million, which was down 15.06% from -$27.7 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Profit After Tax registered a high of -$15.8 million during Q3 2024, and its lowest value of -$77.3 million during Q2 2024.
- For the 3-year period, Tonix Pharmaceuticals Holding's Profit After Tax averaged around -$29.8 million, with its median value being -$27.3 million (2023).
- Within the past 5 years, the most significant YoY rise in Tonix Pharmaceuticals Holding's Profit After Tax was 64.21% (2025), while the steepest drop was 101.02% (2025).
- Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's Profit After Tax stood at -$27.3 million in 2023, then grew by 17.72% to -$22.5 million in 2024, then crashed by 101.02% to -$31.8 million in 2025.
- Its last three reported values are -$31.8 million in Q3 2025, -$27.7 million for Q2 2025, and -$16.1 million during Q1 2025.